|
| |
Inspire Pharmaceuticals Pages on BioPortfolio:
BioPortfolio - Inspire Pharmaceuticals
Inspire Pharmaceuticals - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/5633-Inspire_Pharma...
|
BioPortfolio - farma pharma
Inspire Pharmaceuticals, Inc. (ISPH) Ends U.S., Canada Licensing with FAES Farma 1/14/2008 DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, . ...
http://www.bioportfolio.com/search/farma_pharma.html...
|
BioPortfolio - Inspire Pharmaceuticals - Profile
View the current Inspire Pharmaceuticals Page on BioPortfolio.com .... DiGiTAL50 : Nov 12 2008 8:03PM Matching: inspire pharmaceuticals ...
http://www.bioportfolio.com/biocorporate/5633-Inspire%252BPh...
|
Inspire’s Denufosol tetrasodium (INS37217), a selective P2Y(2 ...
Denufosol tetrasodium (INS37217) is a selective P2Y(2) agonist developed by Inspire Pharmaceuticals that stimulates ciliary beat frequency as well as ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-020505.html...
|
BioPortfolio - Boehringer Ingelheim Pharmaceuticals Inc.
7 Nov 2008 ... Inspire Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript Christy L. ... Boehringer Ingelheim receives method of treatment patent for ...
http://www.bioportfolio.com/search/Boehringer_Ingelheim_Phar...
|
BioPortfolio - pharma tm conference 2008 united kingdom
Biotechnology News Inspire Pharmaceuticals Search MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results ... Officer of OSI Pharmaceuticals, ...
http://www.bioportfolio.com/search/pharma_tm_conference_2008...
|
NASDAQ Biotechnology Companies - icn - myriad
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ... ISPH · INSPIRE PHARMACEUTICALS INC, Nasdaq, Biotech ...
http://www.bioportfolio.com/nasdaq/nasdaq_icn_myriad.htm...
|
BioPortfolio - Resolution Pharmaceuticals
Inspire Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript, Seeking Alpha: Oct 31 2008 9:22PM Matching: resolution pharmaceuticals ...
http://www.bioportfolio.com/biocorporate/8904-Resolution_Pha...
|
BioPortfolio - azasite blepharitis -plus
Although AzaSite (azithromycin ophthalmic solution 1%, Inspire Pharmaceuticals, .... Physicians examine treatment options for patient with blepharitis . ...
http://www.bioportfolio.com/search/azasite_blepharitis_-plus...
|
BioPortfolio - Biocorporate Search
Inspire Pharmaceuticals. Inspire discovers and develops new drugs to treat diseases characterized by deficiencies in the body's innate defense mechanisms
of ...
http://www.bioportfolio.com/biocorporate/search.php?allticke...
|
Results from other life science and pharmaceutical sites:
BioSpace - Inspire Pharmaceuticals, Inc. News, Search Jobs, Events
Inspire Pharmaceuticals, Inc. 4222 Emperor Boulevard Suite 200. Durham North Carolina 27703 U.S.A.. Phone: 919-941-9777 Fax: 919-941-9797 ...
http://www.biospace.com/company_profile.aspx?CompanyId=3172...
|
Live Call: Inspire Pharmaceuticals Earnings Conference Call (Q3 ...
Learn when companies announce their quarterly, annual earnings as well as other types of announcements. Listen to the conference call and remind yourself by ...
http://biz.yahoo.com/cc/5/98105.html...
|
BioPortfolio - Inspire Pharmaceuticals
Inspire Pharmaceuticals - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/5633-Inspire_Pharma...
|
Inspire Pharmaceuticals, Inc. Doubles Treatment Period in Key ...
Investor Contact: Inspire Pharmaceuticals, Inc. Jenny Kobin VP, Investor Relations and Corporate Communications (919) 941-9777, Extension 219 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=104845...
|
BioPortfolio - Inspire Pharmaceuticals - Profile
View the current Inspire Pharmaceuticals Page on BioPortfolio.com .... DiGiTAL50 : Nov 12 2008 8:03PM Matching: inspire pharmaceuticals ...
http://www.bioportfolio.com/biocorporate/5633-Inspire%252BPh...
|
Inspire Pharmaceuticals, Inc.'s Announces Achievement Of Primary ...
DURHAM, NC - JUNE 6, 2008 - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today top-line results from the 352-patient, double-blind, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=99328...
|
Summary of INSPIRE PHARMACEUTICALS INC - Yahoo! Finance
On October 15, 2008, Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) issued a press release, attached to and made part of this report, announcing the issuance ...
http://biz.yahoo.com/e/081016/isph8-k.html...
|
Inspire Pharmaceuticals, Inc. Announces Webcast of Presentation at ...
25 Nov 2008 ... DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=118758...
|
Summary of INSPIRE PHARMACEUTICALS INC - Yahoo! Finance
As previously reported, on July 20, 2007, Inspire Pharmaceuticals, Inc. sold 140186 shares of its Series A Exchangeable Preferred Stock (the "Exchangeable
...
http://biz.yahoo.com/e/071221/isph8-k.html...
|
Inspire Pharmaceuticals Announces Receipt Of Milestone Payment ...
Contact: Inspire Pharmaceuticals, Inc. Investor Contact: Jenny Kobin, 919-941- 9777, ext. 219 Senior Director, Investor Relations or BMC Communications Media
...
http://www.biospace.com/news_story.aspx?NewsEntityId=15719...
|
|
